Elevated Expression of <i>AXL</i> May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients

<table class="table-group" id="tab3"><tr><td><table class="table"><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr class="thead"><td class="align_left">miRNA</td><td class="align_center">Assay number</td></tr><tr><td class="thead-hr" colspan="2"><hr/></td></tr><tr><td class="align_left">RNU48</td><td class="align_center">tm001006</td></tr><tr><td class="align_left">U6</td><td class="align_center">tm001973</td></tr><tr><td class="align_left">miR-199a</td><td class="align_center">tm002304</td></tr><tr><td class="align_left">miR-192</td><td class="align_center">tm000491</td></tr><tr><td class="align_left">miR-34a</td><td class="align_center">tm000426</td></tr><tr class="table-tr"><td colspan="2"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>miRNA-specific TaqMan microRNA assays.</div>

Mediators of Inflammation

tab3

Table 3

Table 3: Elevated Expression of <i>AXL</i> May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients 

Mediators of Inflammation

Elevated Expression of AXL May Contribute to the Epithelial-to-Mesenchymal Transition in Inflammatory Bowel Disease Patients

Table 3